Prevalence of Vaccination among Patients with SARS-CoV-2

Prevalence of Vaccination among Patients with SARS-CoV-2

Saved in:

Bibliographic Details
Main Author:	Falah Hasan Obayes Al-Khikani
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2024-07-01
Series:	Assam Journal of Internal Medicine
Online Access:	https://journals.lww.com/10.4103/ajoim.ajoim_6_24
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Viral Impact on Male Fertility: Current Insights and Implications for SARS-CoV-2
by: Falah Hasan Obayes Al-Khikani
Published: (2025-07-01)

Correction: SARS-CoV-2 vaccines in patients with SLE
Published: (2021-04-01)

Racing for a SARS‐CoV‐2 vaccine
by: Özlem Türeci, et al.
Published: (2021-09-01)

SARS-CoV-2 Alchemy: Understanding the dynamics of age, vaccination, and geography in the evolution of SARS-CoV-2 in India.
by: Mansi Patel, et al.
Published: (2025-03-01)

Risk factors and effectiveness of vaccination for nosocomial SARS-CoV-2 acquisition throughout the SARS-CoV-2 pandemic
by: Nishi Dave, et al.
Published: (2025-08-01)

When leaders fail: Exploring the role of dysfunctional leader cells in autoimmune disease pathogenesis
by: Falah Hasan Obayes AL-Khikani
Published: (2025-06-01)

Immunomodulatory Effect of Amphotericin B Enhances Antiviral Activity
by: Falah Hasan Obayes AL-Khikani
Published: (2020-04-01)

Challenges in Fungal Treatment: A Serious Public Health Problem
by: Falah Hasan Obayes AL-Khikani
Published: (2020-07-01)

Study of the antibiotic-resistant Escherichia coli isolated from urinary tract
by: Falah Hasan Obayes Al-Khikani
Published: (2023-01-01)

When leaders fail: Exploring the role of dysfunctional leader cells in autoimmune disease pathogenesis
by: Falah Hasan Obayes AL-Khikani
Published: (2025-06-01)

Timely development of vaccines against SARS-CoV-2
by: Shan Lu
Published: (2020-01-01)

Pulmonary embolism after SARS-CoV-2 vaccination
by: Björn Zethelius, et al.
Published: (2024-12-01)

New Trends in SARS-CoV-2 Variants and Vaccines
by: Seik-Soon Khor
Published: (2025-03-01)

Vaccination against the SARS-CoV-2 in individuals with comorbidities
by: S A Berns, et al.
Published: (2025-02-01)

Serological response to SARS‐CoV‐2 vaccination in patients with immunobullous diseases
by: B. Levian, et al.
Published: (2024-12-01)

Immunogenicity of Vaccines Against SARS-CoV-2 In Patients With Rheumatic Diseases
by: B. B. BELOV, et al.
Published: (2022-09-01)

Highly Prevalent SARS-CoV-2 Antigenemia in COVID-19 Patients
by: Wenyan Zhang, et al.
Published: (2022-07-01)

Progress in combination vaccines and the co-administration of influenza virus and SARS-CoV-2 vaccines
by: Chengyu Hu, et al.
Published: (2025-06-01)

Acquired immunity against SARS‐CoV‐2 infection and vaccination
by: Laurent Renia, et al.
Published: (2023-11-01)

The influence of SARS-CoV-2 vaccination on in vitro fertilization outcomes
by: Adi Anis Heusler, et al.
Published: (2025-12-01)

Sinopharm Vaccine, SARS-CoV-2 breakthrough infections and Hemoglobinopathies
by: rujittika mungmunpuntipantip, et al.
Published: (2022-06-01)

An improvement of the safety profile of SARS‐CoV‐2 vaccines is desirable
by: Josef Finsterer
Published: (2024-10-01)

Humoral response to SARS-CoV-2 vaccination in lupus nephritis
by: Sofia Fernández, et al.
Published: (2025-01-01)

SARS-CoV-2 vaccine boosters: The time to act is now.
by: Maya Petersen, et al.
Published: (2021-12-01)

Modelling optimal vaccination strategy for SARS-CoV-2 in the UK.
by: Sam Moore, et al.
Published: (2021-05-01)

Booster vaccination against the SARS-CoV-2: mechanisms and efficiency
by: S. A. Berns, et al.
Published: (2023-12-01)

Antibody-dependent enhancement of SARS-CoV-2, the impact of variants and vaccination
by: Swapna Thomas, et al.
Published: (2025-12-01)

Effectiveness and Immunogenicity of the MMR Vaccine Against SARS-CoV-2 Among Healthcare Workers
by: Hyeri Seok, et al.
Published: (2025-02-01)

The rs568408 variant in the IL-12A gene is associated with risk for COVID-19 in Iraqi patients
by: Falah Hasan Obayes AL-Khikani, et al.
Published: (2023-01-01)

A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2.
by: Kwang Su Kim, et al.
Published: (2021-03-01)

Nimble Nimbus and emerging SARS-CoV-2 variants - implications for COVID vaccines
by: Jaffar A. Al-Tawfiq, et al.
Published: (2025-10-01)

A multi-antigen-based SARS-CoV-2 vaccine provides higher immune responses and protection against SARS-CoV-2 variants
by: Marwa Alhashimi, et al.
Published: (2025-07-01)

SARS-CoV-2 Spike Protein Vaccine-Induced Immune Imprinting Reduces Nucleocapsid Protein Antibody Response in SARS-CoV-2 Infection
by: Juan F. Delgado, et al.
Published: (2022-01-01)

Proposed therapies and vaccine developing for COVID-19 (SARS CoV-2)
by: Gamal, Abdelaziz, et al.
Published: (2020-06-01)

Identification of SARS-CoV-2 variants of concern in vaccine-breakthrough infections
by: Baha Abdalhamid, et al.
Published: (2022-04-01)

Adaptation of the Vaccine Prophylaxis Strategy to Variants of the SARS-CoV-2 Virus
by: Sofia M. Gulova, et al.
Published: (2025-07-01)

Pseudoneutralizing test for preclinical studies of vaccines against SARS-CoV-2
by: B. S. Cherepovich, et al.
Published: (2024-04-01)

Analysis of Vaccination Background in Children Undergone SARS-CoV-2 Infection
by: Marina V. Fedoseenko, et al.
Published: (2021-01-01)

Vaccination against SARS-CoV-2 in rheumatic diseases: Safety issues
by: B. S. Belov, et al.
Published: (2022-03-01)

Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern
by: Lei Yue, et al.
Published: (2021-01-01)